Fagron NV/€FAGR
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Fagron NV
Fagron NV is a pharmaceutical company specializing in pharmaceutical compounding, providing personalized medical solutions to hospitals, pharmacies, clinics, and patients across more than 30 countries. The company operates through three segments: Essentials, offering pharmaceutical raw materials and equipment; Brands, developing innovative compounding concepts and formulations; and Compounding Services, delivering ready-to-use medications from its sterile and non-sterile facilities. Founded in 1990 in Rotterdam, the Netherlands, Fagron has expanded its operations globally, with its registered office in Nazareth, Belgium, and operational headquarters in Rotterdam. The company's strategic focus on innovation and quality has enabled it to establish a significant presence in the pharmaceutical compounding market.
Ticker
€FAGR
Sector
Primary listing
BSE
Employees
4,193
Headquarters
Website
Fagron NV Metrics
BasicAdvanced
€1.7bn
18.46
€1.25
-
€0.28
1.22%
Price and volume
Market cap
€1.7bn
52-week high
€25.70
52-week low
€19.34
Average daily volume
73k
Dividend rate
€0.28
Financial strength
Interest coverage (TTM)
6.42%
Profitability
EBITDA (TTM)
170.113
Gross margin (TTM)
43.17%
Net profit margin (TTM)
8.92%
Operating margin (TTM)
14.66%
Effective tax rate (TTM)
20.82%
Revenue per employee (TTM)
€250,000
Management effectiveness
Valuation
Price to earnings (TTM)
18.459
Price to revenue (TTM)
1.64
Dividend yield (TTM)
1.22%
Forward dividend yield
1.22%
Growth
Revenue change (TTM)
11.95%
Earnings per share change (TTM)
6.60%
3-year revenue growth (CAGR)
12.27%
10-year revenue growth (CAGR)
9.35%
3-year earnings per share growth (CAGR)
10.47%
10-year earnings per share growth (CAGR)
-14.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.